<DOC>
	<DOCNO>NCT02275312</DOCNO>
	<brief_summary>The objective study evaluate effectiveness BoNT-A functional improvement patient post-stroke upper and/or lower limb spasticity early stage spasticity development , accord routine clinical practice .</brief_summary>
	<brief_title>ETREAT Study Effectiveness Botulinum Toxin Type A Injections Treat Post-stroke Upper and/or Lower Limb Spasticity</brief_title>
	<detailed_description />
	<mesh_term>Muscle Spasticity</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>Men woman â‰¥ 1880 year . Poststroke limb spasticity . Patients suffer stroke previous 6 month . Treatment goal previously agree patient legal representative . Patients clinically significant poststroke upper/lower limb spasticity , decide perform multidisciplinary treatment BoNTA + rehabilitation . No previous treatment BoNTA . Patient able follow protocol . Written informed consent . Neuromuscular disease . Use drug interfere neuromuscular transmission . Any condition could interfere rehabilitation evaluation result . Diagnosis spasticity associate stroke . Pregnant nursing mother . Prior participation study 6 month study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>